Postoperative changes in the trypsin inhibitor activity of human pancreatic juice and the influence of infusions of a parotid trypsin inhibitor extract (Trasylol, Bayer).
D007611:Aprotinin / Q000008:administration & dosage / Q000494:pharmacology*; D002277:Carcinoma / Q000378:metabolism; D004386:Duodenum / Q000601:surgery; D006801:Humans; D007263:Infusions, Parenteral; D007275:Injections, Intravenous; D010179:Pancreas / Q000378:metabolism; D010189:Pancreatic Juice / Q000187:drug effects*; D010190:Pancreatic Neoplasms / Q000378:metabolism; D010195:Pancreatitis / Q000378:metabolism; D013997:Time Factors; D014361:Trypsin Inhibitors / Q000097:blood*
D014361:Trypsin Inhibitors; D007611:Aprotinin